Drug pricing probes pressure companies
June 21, 2016 | BY
Katherine Jo &clp articlesChina's antitrust regulator has launched an official investigation campaign to unravel the complex supply and distribution networks of drugs and medical devices. Healthcare firms will need to ensure proper pricing conduct and prepare for the surveys and raids
Share:
The National Development and Reform Commission (NDRC) has formally launched a nationwide pricing investigation into China's pharmaceutical and medical devices industries.
The campaign, announced through the May 22 Circular on the Launch of a Dedicated Nationwide Review on the Pricing of Pharmaceuticals (Circular), runs from June 1 to October 31, 2016.